Louisiana Administrative Code
Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS
Part XLV - Medical Professions
Subpart 3 - Practice
Chapter 74 - Collaborative Drug Therapy Management
Subchapter E - Standards of Practice
Section XLV-7425 - Informed Consent
Universal Citation: LA Admin Code XLV-7425
Current through Register Vol. 50, No. 9, September 20, 2024
A. A physician shall not engage in collaborative drug therapy management of a patient without the patient's written informed consent.
B. In addition to the requirements provided by law for obtaining a patient's informed consent, each patient who is subject to collaborative drug therapy management shall be:
1. informed of the collaborative nature of
drug therapy management for the patient's specific medical disease or condition
and provided instructions and contact information for follow-up visits with the
physician and pharmacist;
2.
informed that he or she may decline to participate in a collaborative drug
therapy management practice and may withdraw at any time without terminating
the physician-patient relationship; and
3. provided written disclosure of any
contractual or financial arrangement with any other party that may impact one
of the party's decisions to participate in the agreement.
AUTHORITY NOTE: Promulgated in accordance with R.S. 37:1270(A)(1), 1270(B)(6) and 37:1164(37).
Disclaimer: These regulations may not be the most recent version. Louisiana may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
